Sarepta Therapeutics (SRPT)

• Market cap: $1.97B
• 1 day: 5.56%
• 5 days: 3.75%
• 1 month: -12.23%
• 3 months: -7.34%
• 6 months: -47.37%
• Year to date: -84.84%
• 1 year: -82.76%
• 5 years: -86.54%
• 10 years: -27.49%
• Sector: Healthcare
• Industry: Biotechnology

About: Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.

Employees: 1,372